Diane recently served as Chief Commercial Officer for Better Therapeutics, where she focused on the company’s commercial capabilities and led the launch of AspyreRx, an FDA-authorized prescription digital therapeutic delivering cognitive behavioral therapy for the treatment of Type II Diabetes.

Prior to Better Therapeutics, was the U.S. President of Galderma responsible for integrating its aesthetic, consumer care and prescription medicines business units following its divestiture from Nestlé.

From 2003 to 2021, Diane spent nearly two decades at Johnson & Johnson in strategic and commercial roles in its medtech sector ultimately serving as the Worldwide President of Mentor, a women’s surgical breast aesthetics business.

Diane began at J&J as a member of the Cordis team who launched Cypher, the first drug eluting stent. At Ethicon, Diane led the Biosurgery franchise and commercialized the Evarrest fibrin sealant patch for rapid hemostasis of problematic bleeding in surgery.

Diane serves as an Executive Strategic Advisor to InSoma Biotech, an early-stage start-up developing novel injectable material to mimic human tissue. She serves on the Board of Directors for Workforce Solutions Dallas, appointed by Dallas Mayor Eric Johnson. Diane also sits on the Board of the Association of Latino Princeton Alumni.